Petit Institute Executive Director Candidate Town Hall

Event Details
  • Date/Time:
    • Tuesday May 15, 2018 - Wednesday May 16, 2018
      11:00 am - 11:59 am
  • Location: Clough Commons, Room 144
  • Phone:
  • URL:
  • Email:
  • Fee(s):
  • Extras:

Lisa Tuttle
Office of Stephen Cross
Executive Vice President for Research
Georgia Tech


Summary Sentence: M.G. Finn, Ph.D. - Georgia Tech

Full Summary: No summary paragraph submitted.

  • M.G. Finn, Ph.D. - Georgia Tech M.G. Finn, Ph.D. - Georgia Tech

M.G. Finn, Ph.D.
Professor and Chair
James A. Carlos Family Chair for Pediatric Technology
School of Chemistry and Biochemistry
Georgia Tech


In the Finn lab, we develop chemical and biological tools for research in a wide range of fields. Some of them are briefly described below; please see our group web page for more details.

Chemistry, biology, immunology, and evolution with viruses. The sizes and properties of virus particles put them at the interface between the worlds of chemistry and biology. We use techniques from both fields to tailor these particles for applications to cell targeting, diagnostics, vaccine development, catalysis, and materials self-assembly. This work involves combinations of small-molecule and polymer synthesis, bioconjugation, molecular biology, protein design, protein evolution, bioanalytical chemistry, enzymology, physiology, and immunology. It is an exciting training ground for modern molecular scientists and engineers.

Development of reactions for organic synthesis, chemical biology, and materials science.  Molecular function is what matters most to our scientific lives, and good chemical reactions provide the means to achieve such function. We continue our efforts to develop and optimize reactions that meet the click chemistry standard for power and generality. Our current focus is on highly reliable reversible reactions, which open up new possibilities for polymer synthesis and modification, as well as for the controlled delivery of therapeutic and diagnostic agents to biological targets.

Traditional and combinatorial synthesis of biologically active compounds.  We have a longstanding interest in the development of biologically active small molecules. We work closely with industrial and academic collaborators on such targets as antiviral agents, compounds to combat tobacco addiction, and treatments for inflammatory disease.

Related Links

Additional Information

In Campus Calendar

Parker H. Petit Institute for Bioengineering and Bioscience (IBB), Wallace H. Coulter Dept. of Biomedical Engineering

Invited Audience
Faculty/Staff, Postdoc, Public, Graduate students, Undergraduate students
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Apr 30, 2018 - 12:19pm
  • Last Updated: Apr 30, 2018 - 1:11pm